FDA Inspection 1034913 — Gregoire Le Gal, M.D.
The FDA completed an inspection of Gregoire Le Gal, M.D. on Sep 21, 2017 in Ottawa. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 21, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Ottawa (Canada)
Additional details
Clinical Investigator (CI)